focus -WSS

focus

author：entertainment 2025-09-28 15:55:13 - browse：4

President of Bayer U.S. Sebastian Guth speaks with STAT reporters at STAT's Boston headquarters, March 13, 2024 — Bayer's U.S. president, Sebastian Guth, emphasized at an interview at the STAT offices in Boston that the pharma company is no longer just focused on small molecules. Alissa Ambrose/STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom.

Bayer’s C-suite has been on a soul-searching mission for the last year, spurred by new leadership and the realization that the company is, as new CEO Bill Anderson said earlier this month, “badly broken.”

The biggest fissure is the debt and litigation costs stemming from Bayers’s 2018 acquisition of agriculture firm Monsanto, but the aspirin-maker’s pharmaceutical portfolio is also facing strain. Some of Bayer’s top products, including the anticoagulant drug Xarelto and the eye medication Eylea, are under patent pressure. Xarelto is also one of the first drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, though Johnson & Johnson owns U.S. rights to the drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： 'Investigate these claims': UFO transparency at center of House hearing

WSS

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

A bus careens into a gulch in southern Mexico, leaving 27 people dead

The haunting brain science of long Covid

What it's like to live with paralysis for one psychologist

Search called off for baby washed away in Pennsylvania flash flood

Democrats decry new health bill for going easy on private equity

focus

focus

focus

The high cost of giving birth even with insurance

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Novavax promises a turnaround & Lilly roils the obesity market

Following judge's order, DOJ releases slightly less

23andMe had bad news about my health. I wish a person had delivered it

Israel withdraws forces after 2

Apple is now the first public company to be valued at $3 trillion

Roche’s Alnylam deal shows drug firms interested in heart drugs

Affirmative action in medical school literally saved lives

Device maker Teleflex to acquire urology company for $600M

hotspot

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Dems pitch expanding Medicare power to negotiate drug prices

In the gardens at Boston Children's Hospital, families find sanctuary

The leaders of Italy and Poland say European Union should focus on stopping migration

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

Princess Kate attends Wimbledon with Roger Federer: See the photos

knowledge

hotspot

hotspot

explore